{"id":"W4417009748","doi":"10.1182/blood-2025-5353","title":"Fixed-duration subcutaneous mosunetuzumab continues to demonstrate high rates of durable responses in patients with relapsed/refractory follicular lymphoma after ≥2 prior therapies: 3-year follow-up from a pivotal Phase II study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Dosing; Complete response; Phases of clinical research; Progressive disease; Follicular phase; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00274106,0.0004399358,0.001035808,0.0002002528,0.0003522127,0.0009336118,0.0003861173,0.0005171786,0.001514326],"category_scores_gemma":[0.001356278,0.000188311,0.000773819,0.0002938187,0.0002776569,0.0005879211,0.0002143438,0.00122171,0.0004644844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004856481,"about_ca_system_score_gemma":0.0004404612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004682914,"about_ca_topic_score_gemma":0.0009552908,"domain_scores_codex":[0.9992921,0.0002584566,0.00006562185,0.0001235906,0.0001193447,0.0001407739],"domain_scores_gemma":[0.9988199,0.0002732816,0.000355658,0.0001580942,0.00012253,0.0002704764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2665189,0.01475294,0.1341462,0.001076864,0.003365103,0.0006908251,0.0005245746,0.002536908,0.1120486,0.0002374132,0.009576322,0.4545254],"study_design_scores_gemma":[0.06389453,0.3718896,0.5141767,0.0001577649,0.002933607,0.002203241,0.0002177556,0.003421619,0.02388019,0.0002870505,0.01686341,0.00007453281],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905202,0.00555075,0.0006651607,0.0001886357,0.00004345847,0.0003513203,0.0007473655,0.00007014266,0.001862871],"genre_scores_gemma":[0.9970446,0.00068356,0.0002595392,0.0002637692,0.00004150295,0.0001154502,0.001128921,0.00001158321,0.0004510059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00274106,"threshold_uncertainty_score":0.01449627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008669991846502094,"score_gpt":0.2697400038793466,"score_spread":0.2610700120328445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}